Fisetin: A Senolytic That Extends Life

Fisetin has demonstrated robust systemic health benefits. Lifespan increases occur even when fisetin is initiated in old age. A novel formulation increases fisetin bioavail ability.

Scientifically reviewed by: Dr. Gary Gonzalez, MD, on January 2021. Written By Charles Wyatt.

Senolytics have been shown to improve health and extend lifespan in experimental models.

These compounds work by helping the body clear away old, damaged (senescent) cells to make way for new, healthy cells.

Fisetin, a flavonoid found in various plants, is one of the most powerful natural senolytics ever discovered.

Preclinical and some preliminary clinical studies suggest it may protect against age-related disorders,^1-15 slow certain aging processes, and promote longevity.^10,16

Old mice given fisetin had a nearly 10% increase in lifespan.¹⁷

One challenge has been that fisetin is rapidly metabolized in the digestive tract. This means very little is absorbed into the blood stream.

But scientists have developed a way to overcome this problem by combining it with natural compounds from the fenugreek plant. 

This novel formulation increased the bioavailability of fisetin by as much as 25 times.¹⁸

What Is Fisetin?

Fisetin is a flavonoid that has gained popularity in recent years due to its potential health benefits.

It is found in small amounts in many fruits and vegetables, including strawberries, apples, persimmons, grapes, and onions.

Fisetin shares some of the anti-aging, disease-fighting properties of other polyphenols. Yet it stands out for its remarkable potency as a senolytic. ¹⁷

Improved Bioavailability

There’s long been a problem with oral fisetin. Soon after ingestion, it is rapidly metabolized in the gut, making it much less effective.

Scientists have now solved this problem by combining fisetin with a form of fiber known as galactomannans, isolated from the spice fenugreek.

This novel formulation has been shown to increase the bioavailability (absorption) of fisetin by as much as 25 times, which may greatly improve its impact on health and longevity.¹⁸

A Powerful Senolytic

Senescent cells are aged cells that stop functioning properly and can cause damage to surrounding tissues. They lose the ability to grow or divide, and they refuse to die off, earning them the name “zombie cells.”

These senescent cells spew out compounds that incite harmful systemic inflammation inflicting even more damage.^19,20

Senescent cells are a major driver of age-related disease and dysfunction. They even accelerate the aging process itself.

Senolytics are compounds with the ability to destroy senescent cells. They hold great promise in the fight against aging and age-related disease, slowing or even reversing the aging process.^16,17,21,22

One of the first senolytics discovered was another polyphenol, quercetin, which works effectively when coupled with a chemotherapy drug, dasatinib.

Fisetin is a more powerful senolytic than quercetin. And it works on its own, without the potential side effects of cancer drugs.

A cell study published in the journal Aging showed that it eliminated about 70% of senescent cells—while doing no harm to healthy, normal human cells. ²²

Another study tested 10 plant-derived compounds, including quercetin, head-to-head. Fisetin was the most effective at eliminating senescent cells, both in cell cultures and in an animal model.¹⁷

These findings suggest fisetin may be an effective weapon in the fight against aging.

There are a number of human trials of fisetin currently in progress.²³ But an animal study has already shown striking results.

When mice that were the human equivalent of 75 years of age were given fisetin, they lived an average of 2.5 months longer. That’s close to a 10% increase in lifespan.¹⁷

Fighting Oxidative Stress and Inflammation

Fisetin promotes longevity in several other ways. Oxidative stress and chronic inflammation accelerate aging processes and increase risk for chronic diseases.

It reduces inflammation by shutting off pathways that promote it, and by reducing the production of pro-inflammatory compounds.¹⁰

Mimicking Caloric Restriction

Reducing food intake through a calorie-restricted diet has been shown to slow aging, extend lifespan, and improve resistance to disease. ²⁵

Research has identified the cellular pathways that are affected by such a diet. Among other benefits, caloric restriction:²⁶

• Reduces the activity of mTOR, a protein linked to aging, weight gain, and chronic disease,
• Boosts the function of sirtuins, proteins that regulate cellular health,
• Increases the activity of AMPK, an enzyme that regulates metabolism, and
• Promotes autophagy, cellular “housekeeping.”

Researchers have found that fisetin has a similar effect on every one of these pathways, mimicking the effects of caloric restriction.^10,16,27,28

For example, sirtuin proteins shield cells from damage and help keep them in peak form. But sirtuin function diminishes with age, leading to increased susceptibility to disease and rapid aging.^29,30

AMPK activity also declines with age, increasing risk for deteriorating metabolic function, obesity, diabetes, and more.³¹

Several preclinical studies have shown that fisetin increases sirtuin function and AMPK activity.^32-34 This protects cells and keeps them on a youthful and healthy path.

WHAT YOU NEED TO KNOW

The Senolytic Power of Fisetin

• Fisetin is a flavonoid found in several fruits and vegetables, including strawberries, apples, grapes, and onions.
• Fisetin is one of the most potent senolytics yet discovered among plant-derived polyphenols, destroying dysfunctional senescent cells and extending lifespan by approximately 10% in animal studies.
• This compound has been shown in preclinical studies to protect against cancer, diabetes, and obesity. In a human trial, it improved outcomes in stroke victims.
• Taken orally, fisetin is rapidly metabolized in the digestive tract. Scientists have discovered that combining it with galactomannans from fenugreek prevents that from happening.
• A new formulation boosts the bioavailability of oral fisetin by as much as 25 times, allowing more of it to circulate throughout the body, which may promote longevity and better health.

Protecting the Heart

Fisetin not only has the ability to extend lifespan in preclinical models, it may also reduce the risk for many of the most common chronic illnesses.

Heart disease remains the leading cause of death in the U.S. Most common forms of heart disease are due to inadequate flow of blood, oxygen, and nutrients to the heart, which can lead to a heart attack.

Over the last two years, studies have demonstrated that fisetin can protect the heart from injury. Even after heart attack models, heart cells fare better when fisetin is present.

In one recent study published in the journal Nature, rat heart cells starved for nutrients and oxygen were protected by fisetin, preventing cell death.³⁵

And in animal models of heart attack, the extent of heart damage was reduced when treated with fisetin, preserving better heart function. ^36,37

In humans who suffer a heart attack, an arrhythmia (abnormal heart rhythm) can often develop.³⁸ In an animal study, fisetin intake after a heart attack significantly reduced the risk of atrial fibrillation, a common arrhythmia that increases the likelihood of stroke or heart failure.³⁹

Preventing Obesity and Metabolic Disorders

Fisetin may also help to prevent obesity and common metabolic disorders, like type II diabetes.

Obesity predisposes people to higher rates of cardiovascular disease as well as cancer, dementia, and many other conditions.

By increasing activity of AMPK and decreasing activity of mTOR, fisetin may reduce weight gain and protect against related disorders. Even in mice fed a high-fat diet, fisetin prevented weight gain while protecting the liver, heart, and other organs.^5,10,40,41

Rodent models of diabetes find that fisetin reduces body weight and improves glucose control and insulin sensitivity.^4,12,40-42

Having better glucose control can protect against many of the diabetic complications, like kidney disease, eye disease, and neurological disorders.

Life Extension has long suggested the importance of keeping fasting blood glucose between 70-85 mg/dL, which is challenging for most aging people to accomplish. Fisetin may offer a solution to stubbornly high glucose levels.

Fighting Cancer

As an anti-inflammatory, fisetin may lower the risk of developing cancer. ^43-46 But fisetin’s anti-cancer activity goes even further.

Two recent preclinical studies have shown fisetin to be effective in controlling even some of the most aggressive forms of cancer.

In one, scientists investigated the impact of fisetin on human glioblastoma cells.⁴⁷ Glioblastoma, a malignant brain tumor, is one of the most invasive and rapidly growing forms of cancer. Even with surgery and chemotherapy, it is usually impossible to control.

Fisetin treatment significantly reduced the growth of glioblastoma cells and even caused them to die off. When directly compared to a chemotherapy drug called carmustine, fisetin killed cancer cells at lower doses.

In another recent study, fisetin was effective against several cell lines of triple negative breast cancer. This aggressive form of breast cancer is highly resistant to most medical treatments.⁴⁸

In several other studies, fisetin prevented cancer migration and growth while reducing inflammation, enhancing autophagy, and inciting cancer cell death.^11,49-55

Fisetin may one day be considered as an adjuvant nutritional approach by progressive oncologists.

Brain Benefits

Fisetin has been demonstrated to be neuroprotective in animal models of Alzheimer’s disease, Parkinson’s disease, ALS (amyotrophic lateral sclerosis), and others.^1-3,8-10,15

In a 2019 clinical study, fisetin was found to help in the treatment of a stroke.

Strokes typically occur suddenly, without warning, and can lead to permanent loss of brain function. The most effective medical treatments dissolve or remove the blood clot blocking blood flow to the brain.

But the best chance for success comes when treatment is initiated within three hours of the onset of symptoms.⁵⁶

Fisetin has been shown to extend this treatment window to five hours.¹³ While this two-hour extension may not seem huge, it can dramatically increase the number of stroke patients who benefit from clot dissolving and/or clot removing (endovascular thrombectomy) brain-saving therapy.

Summary

Fisetin is a flavonoid found in several fruits and vegetables, such as strawberries and apples.

Recent research has found fisetin to be one of the most effective senolytic compounds yet discovered among plant polyphenols. By helping to remove dysfunctional senescent cells, fisetin may increase longevity and lower risk for disease.

In mice, fisetin intake increased lifespan by nearly 10%, even when started late in life.

Combining fisetin with compounds isolated from fenugreek allows more fisetin to be absorbed and distributed in the body to aging tissues that can benefit from its health-promoting actions.

If you have any questions on the scientific content of this article, please call a Life Extension® Wellness Specialist at 1-866-864-3027.

References

1. Ahmad A, Ali T, Park HY, et al. Neuroprotective Effect of Fisetin Against Amyloid-Beta-Induced Cognitive/Synaptic Dysfunction, Neuroinflammation, and Neurodegeneration in Adult Mice. Mol Neurobiol. 2017 Apr;54(3):2269-85.
2. Alikatte K, Palle S, Rajendra Kumar J, et al. Fisetin Improved Rotenone-Induced Behavioral Deficits, Oxidative Changes, and Mitochondrial Dysfunctions in Rat Model of Parkinson’s Disease. J Diet Suppl. 2020 Jan 29:1-15.
3. Chen C, Yao L, Cui J, et al. Fisetin Protects against Intracerebral Hemorrhage-Induced Neuroinflammation in Aged Mice. Cerebrovasc Dis. 2018;45(3-4):154-61.
4. Ge C, Xu M, Qin Y, et al. Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation. Food Funct. 2019 May 22;10(5):2970-85.
5. Jung CH, Kim H, Ahn J, et al. Fisetin regulates obesity by targeting mTORC1 signaling. The Journal of Nutritional Biochemistry. 2013;24(8):1547-54.
6. Khan N, Afaq F, Syed DN, et al. Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells. Carcinogenesis. 2008 May;29(5):1049-56.
7. Li J, Cheng Y, Qu W, et al. Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells. Basic Clin Pharmacol Toxicol. 2011 Feb;108(2):84-93.
8. Maher P. Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin. Genes & Nutrition. 2009 Dec;4(4):297-307.
9. Maher P, Akaishi T, Abe K. Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16568-73.
10. Pal HC, Pearlman RL, Afaq F. Fisetin and Its Role in Chronic Diseases. Adv Exp Med Biol. 2016;928:213-44.
11. Suh Y, Afaq F, Johnson JJ, et al. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways. Carcinogenesis. 2009 Feb;30(2):300-7.
12. Vinayagam R, Xu B. Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutrition & Metabolism. 2015;12(1):60.
13. Wang L, Cao D, Wu H, et al. Fisetin Prolongs Therapy Window of Brain Ischemic Stroke Using Tissue Plasminogen Activator: A Double-Blind Randomized Placebo-Controlled Clinical Trial. Clinical and Applied Thrombosis/Hemostasis. 2019 Jan-Dec;25:1076029619871359.
14. Ying TH, Yang SF, Tsai SJ, et al. Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway. Arch Toxicol. 2012 Feb;86(2):263-73.
15. Zhang L, Wang H, Zhou Y, et al. Fisetin alleviates oxidative stress after traumatic brain injury via the Nrf2-ARE pathway. Neurochemistry International. 2018 Sep;118:304-13.
16. Grynkiewicz G, Demchuk OM. New Perspectives for Fisetin. Front Chem. 2019;7:697.
17. Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018 Oct;36:18-28.
18. Akay. A cross over pilot pharmacokinetic study of fisetin 1000mg and formulated fisetin 200mg administered in a single dose to healthy volunteers. Manufacturer’s study (in press for future publication). 2020.
19. Dodig S, Cepelak I, Pavic I. Hallmarks of senescence and aging. Biochem Med (Zagreb). 2019 Oct 15;29(3):030501.
20. Zhu Y, Armstrong JL, Tchkonia T, et al. Cellular senescence and the senescent secretory phenotype in age-related chronic diseases. Current Opinion in Clinical Nutrition and Metabolic Care. 2014 Jul;17(4):324-8.
21. Pallauf K, Duckstein N, Rimbach G. A literature review of flavonoids and lifespan in model organisms. Proceedings of the Nutrition Society. 2016 May;76(2):145-62.
22. Zhu Y, Doornebal EJ, Pirtskhalava T, et al. New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging. 2017 Mar 8;9(3):955-63.
23. Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020 Nov;288(5):518-36.
24. Naeimi AF, Alizadeh M. Antioxidant properties of the flavonoid fisetin: An updated review of in vivo and in vitro studies. Trends in Food Science & Technology. 2017 2017/12/01/;70:34-44.
25. Anton S, Leeuwenburgh C. Fasting or caloric restriction for healthy aging. Exp Gerontol. 2013 Oct;48(10):1003-5.
26. Lopez-Lluch G, Navas P. Calorie restriction as an intervention in ageing. J Physiol. 2016 Apr 15;594(8):2043-60.
27. Khan N, Syed DN, Ahmad N, et al. Fisetin: A Dietary Antioxidant for Health Promotion. Antioxidants & Redox Signaling. 2013 Jul 10;19(2):151-62.
28. Singh S, Singh AK, Garg G, et al. Fisetin as a caloric restriction mimetic protects rat brain against aging induced oxidative stress, apoptosis and neurodegeneration. Life Sci. 2018 Jan 15;193:171-9.
29. Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014 Aug;24(8):464-71.
30. Johnson S, Imai SI. NAD (+) biosynthesis, aging, and disease. F1000Res. 2018;7:132.
31. Burkewitz K, Zhang Y, Mair WB. AMPK at the nexus of energetics and aging. Cell Metab. 2014 Jul 1;20(1):10-25.
32. Bai X, Yao L, Ma X, et al. Small Molecules as SIRT Modulators. Mini-Reviews in Medicinal Chemistry. 2018;18(13):1151-7.
33. Liou C-J, Wei C-H, Chen Y-L, et al. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice. Cellular Physiology and Biochemistry. 2018;49(5):1870-84.
34. Yang W, Tian ZK, Yang HX, et al. Fisetin improves lead-induced neuroinflammation, apoptosis and synaptic dysfunction in mice associated with the AMPK/SIRT1 and autophagy pathway. Food Chem Toxicol. 2019 Dec;134:110824.
35. Rodius S, de Klein N, Jeanty C, et al. Fisetin protects against cardiac cell death through reduction of ROS production and caspases activity. Sci Rep. 2020 Feb 19;10(1):2896.
36. Long L, Han X, Ma X, et al. Protective effects of fisetin against myocardial ischemia/reperfusion injury. Exp Ther Med. 2020 May;19(5):3177-88.
37. Garg S, Khan SI, Malhotra RK, et al. The molecular mechanism involved in cardioprotection by the dietary flavonoid fisetin as an agonist of PPAR-gamma in a murine model of myocardial infarction. Arch Biochem Biophys. 2020 Nov 15;694:108572.
38. Available at: https://emedicine.medscape.com/article/164924-overview#a2. Accessed November 4, 2020.
39. Liu L, Gan S, Li B, et al. Fisetin Alleviates Atrial Inflammation, Remodeling, and Vulnerability to Atrial Fibrillation after Myocardial Infarction. Int Heart J. 2019 Nov 30;60(6):1398-406.
40. Choi MS, Choi JY, Kwon EY. Fisetin Alleviates Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice. J Med Food. 2020 Oct;23(10):1019-32.
41. Hu LF, Feng J, Dai X, et al. Oral flavonoid fisetin treatment protects against prolonged high-fat-diet-induced cardiac dysfunction by regulation of multicombined signaling. J Nutr Biochem. 2020 Mar;77:108253.
42. Kan E, Kiliçkan E, Ayar A, et al. Effects of two antioxidants; α-lipoic acid and fisetin against diabetic cataract in mice. International Ophthalmology. 2014 Feb;35(1):115-20.
43. Kashyap D, Garg VK, Tuli HS, et al. Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential. Biomolecules. 2019 May 6;9(5):174.
44. Kashyap D, Sharma A, Sak K, et al. Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy. Life Sci. 2018 Feb 1;194:75-87.
45. Park H-H, Lee S, Son H-Y, et al. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Archives of Pharmacal Research. 2008 Oct;31(10):1303-11.
46. Wang L, Tu YC, Lian TW, et al. Distinctive antioxidant and antiinflammatory effects of flavonols. J Agric Food Chem. 2006 Dec 27;54(26):9798-804.
47. Pak F, Oztopcu-Vatan P. Fisetin effects on cell proliferation and apoptosis in glioma cells. Z Naturforsch C J Biosci. 2019 Nov 26;74(11-12):295-302.
48. Shahi Thakuri P, Gupta M, Singh S, et al. Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling. BMC Cancer. 2020;20(1):4-.
49. Bhat TA, Nambiar D, Pal A, et al. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention. Carcinogenesis. 2012 Feb;33(2):385-93.
50. Farsad-Naeimi A, Alizadeh M, Esfahani A, et al. Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients. Food & Function. 2018 Apr 25;9(4):2025-31.
51. Jia S, Xu X, Zhou S, et al. Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways. Cell Death & Disease. 2019;10(2):142-.
52. Kang KA, Piao MJ, Madduma Hewage SR, et al. Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the MAPK signaling pathway. Tumour Biol. 2016 Jul;37(7):9615-24.
53. Li J, Gong X, Jiang R, et al. Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3beta Signal Pathway. Front Pharmacol. 2018;9:772.
54. Lim JY, Lee JY, Byun BJ, et al. Fisetin targets phosphatidylinositol-3-kinase and induces apoptosis of human B lymphoma Raji cells. Toxicology Reports. 2015 2015/01/01/;2:984-9.
55. Ravichandran N, Suresh G, Ramesh B, et al. Fisetin modulates mitochondrial enzymes and apoptotic signals in benzo(a)pyrene-induced lung cancer. Mol Cell Biochem. 2014 May;390(1-2):225-34.
56. Available at: https://www.ncbi.nlm.nih.gov/books/NBK507917/. Accessed September 1, 2020.